- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Middle East and Africa High Throughput Screening Market Size
The size of the Middle East and Africa high throughput screening market was worth USD 30.77 billion in 2024. The market is anticipated to grow at a CAGR of 6.9% from 2025 to 2033 and be worth USD 56.10 billion by 2033 from USD 32.89 billion in 2025.
MARKET DRIVERS
Technological Advancements and Rising Demand for Drug Discovery Tools
The rise in the number of potential drug targets and advancements in technologies leading to the emergence of innovative technologies and platforms like analytical tools that deal with massive amounts of data drive market growth. In addition, growth in demand for high throughput screening devices in stem cell research for assessing excretion, metabolism, distribution, and absorption characteristics and investigation of functional activity are significant drivers of the Middle East and Africa high throughput screening market. Also, the availability of government funding, collaborations of research, and academic institutions with pharmaceutical industries for developing innovative ways for drug delivery are further catalyzing the growth of the Middle East and Africa high throughput screening market.
The factors that provide growth opportunities for expanding the high throughput screening market during the forecast period are the evolution of preclinical drug development and discovery systems by adopting human stem cell-based high throughput screenings and assays. Emerging economies of countries are increasing the market's growth opportunities due to rapid growth in pharmaceutical industries and the integration of innovative technologies, a significant push for research by governments of these countries in the life sciences industry.
MARKET RESTRAINTS
High Costs and Budget Constraints in Research and Automation
Restraints challenging the growth of the high throughput screening market are costs, the requirement of extensive automation techniques, the capital-intensive nature, and budget restrictions for academic research purposes. There is an increased requirement for instruments in biotechnological and pharmacy companies, resulting in a notable rise in these companies' capital costs that are expected to limit the Middle East and Africa high throughput screening market during the forecast period.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2024 to 2033 |
| Base Year | 2024 |
| Forecast Period | 2025 to 2033 |
| Segments Covered | By Product, Technology, Application, End User, and Region. |
| Various Analyses Covered | Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Countries Covered | KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of Middle East and Africa |
| Market Leaders Profiled | Agilent Technologies Inc., Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Tecan Group Ltd., Millipore, Bio-Rad Laboratories, Hamilton Company, Axxam S.p.A. |
REGIONAL ANALYSIS
Regionally, South Africa and Saudi Arabia witnessed to grow with the highest CAGR in the Middle East and Africa high throughput screening market during the forecast period. Technological advancements in high throughput growing pharmaceutical research and development expenses are likely to fuel the market growth during the historical period. In addition, the availability of funds from the government integrated with developing common diseases is propelling the market.
Other countries like UAE, Ethiopia, Israel, Sudan, Kenya, Egypt, and the rest of the Middle East and Africa are expected to grow in the region's market.
KEY MARKET PARTICIPANTS
Agilent Technologies Inc., Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Tecan Group Ltd., Millipore, Bio-Rad Laboratories, Hamilton Company, Axxam S.p.A., and Aurora Biomed are some of the notable companies in the Middle East and Africa high throughput screening market.
MARKET SEGMENTATION
This research report on the Middle East and Africa high throughput screening market has been segmented and sub-segmented into the following categories
By Product
-
Consumables And Reagents
- Instruments
- Software And Services
By Technology
-
Cell-based Assays
- Lab-on-a-chip
- Ultra-High-Throughput Screening
- Label-Free Technology
- Bioinformatics
By Application
-
Target Identification
- Primary Screening
- Toxicology
- Others
By End User
-
Pharmaceutical and Biotechnology Companies
- Academic and Government Research Institutes
- Contract Research Organizations
- Other End Users
By Country
- KSA
- UAE
- Israel
- rest of GCC countries
- South Africa
- Ethiopia
- Kenya
- Egypt
- Sudan
- rest of Middle East and Africa
